Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Palam Pharma is a private Indian pharmaceutical company focused on the manufacturing and export of active pharmaceutical ingredients (APIs). The company appears to operate primarily as a commercial-stage small-molecule API manufacturer and supplier rather than a drug developer with a disclosed clinical pipeline. Its marketed and manufacturing portfolio includes APIs such as dicyclomine hydrochloride, fluoxetine hydrochloride, clomiphene citrate, proguanil hydrochloride, and clotrimazole. Palam Pharma presents itself as an integrated, research-oriented pharma business with in-house R&D support for process validation and quality specifications, serving domestic and international pharmaceutical customers from Ahmedabad, Gujarat.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Palam Pharma.